Droits & Societe
EMA consults on reducing animal use
The European Medicines Agency (EMA) is consulting on a draft qualification opinion for a new methodology in preclinical research aimed at reducing animal use in medicines development. The new methodology involves virtual control groups, which could reduce the overall number of animals needed in research. The EMA's human medicines committee (CHMP) is seeking feedback on the approach. This initiative reflects the EU's commitment to the 3Rs principles (Replacement, Reduction, Refinement) regarding animal use in research.
EMA consults on methodology to reduce animal testing for new medicines.